The Role of Oxidative Stress on Necrotizing Enterocolitis in Very Low Birth Weight Infants

被引:44
作者
Perrone, Serafina [1 ]
Tataranno, Maria Luisa [1 ]
Santacroce, Antonino [1 ]
Negro, Simona [1 ]
Buonocore, Giuseppe [1 ]
机构
[1] Univ Siena, Dept Mol & Dev Med, Siena, Italy
关键词
Antioxidant; biomarkers; necrotizing enterocolitis; oxidative stress; preterm infants;
D O I
10.2174/1573396309666140101235126
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Necrotizing enterocolitis (NEC) is a devastating and common disease of very low birth weight (VLBW) infants with a mortality rate of 10% to 50% and a significant cause of morbidity in survivors. The incidence of NEC has increased from 5% to 7% in the last decades and this rate is likely to rise because of the increased survival of infants born at 24 weeks gestation, which are at high risk of developing NEC. NEC etiology is multifactorial: ischemia, infections, cytokines, enteral feeding and reactive oxygen species or free radicals (FRs) may contribute to the disruption of the immature gut barrier. In particular, ischemia, hypoxia-reperfusion, infection and inflammation are mechanisms capable of producing high levels of FRs, perturbing the normal redox balance and shifting cells to a state of oxidative stress (OS). Despite advances in neonatal medicine, the early diagnosis of NEC remains a major challenge. Early clinical signs are non specific and the laboratory findings are not fully reliable. Therefore, its delayed occurrence after birth, its rapid onset, the highly fulminant nature, and its severe morbidity, as well as the possibility of progression to death, strongly require the identification of new prospective biomarkers specific for high NEC risk. There is evidences that OS biomarkers in cord blood allow the early identification of infants at risk for NEC and thereby can be used to develop novel therapies for this devastating disease which predominantly occurs in premature infants.
引用
收藏
页码:202 / 207
页数:6
相关论文
共 71 条
[61]   BIOLOGICAL ROLE OF LACTOFERRIN [J].
SANCHEZ, L ;
CALVO, M ;
BROCK, JH .
ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (05) :657-661
[62]   Necrotizing enterocolitis: A multifactorial disease with no cure [J].
Schnabl, Kareena L. ;
Van Aerde, John E. ;
Thomson, Alan Br ;
Clandinin, Michael T. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (14) :2142-2161
[63]   Roles of cytosolic phospholipase A2 and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF [J].
Shindou, H ;
Ishii, S ;
Uozumi, N ;
Shimizu, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 271 (03) :812-817
[64]   Long-term follow-up of patients with necrotizing enterocolitis [J].
Stanford, A ;
Upperman, JS ;
Boyle, P ;
Schall, L ;
Ojimba, JI ;
Ford, HR .
JOURNAL OF PEDIATRIC SURGERY, 2002, 37 (07) :1048-1050
[65]   Regulation of platelet-activating factor (PAF) biosynthesis via coenzyme A-independent transacylase in the macrophage cell line IC-21 stimulated with lipopolysaccharide [J].
Svetlov, SI ;
Liu, HL ;
Chao, W ;
Olson, MS .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1997, 1346 (02) :120-130
[66]   Necrotizing enterocolitis in newborns - Pathogenesis, prevention and management [J].
Thompson, Alecia M. ;
Bizzarro, Matthew J. .
DRUGS, 2008, 68 (09) :1227-1238
[67]   The extent to which genotype information may add to the prediction of distrurbed perinatal adaption:: none, minor, or major? [J].
Treszl, Andras ;
Kaposi, Ambrus ;
Hajdu, Jolia ;
Szabo, Miklos ;
Tulassay, Tivadar ;
Vasarhelyi, Barna .
PEDIATRIC RESEARCH, 2007, 62 (05) :610-614
[68]  
Weinberg ED, 2003, EXPERT OPIN INV DRUG, V12, P841
[69]   Human lactoferrin: a novel therapeutic with broad spectrum potential [J].
Weinberg, ED .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (10) :1303-1310
[70]   Advanced oxidation protein products as a novel marker of oxidative stress in uremia [J].
WitkoSarsat, V ;
Friedlander, M ;
CapeillereBlandin, C ;
NguyenKhoa, T ;
Nguyen, NT ;
Zingraff, J ;
Jungers, P ;
DescampsLatscha, B .
KIDNEY INTERNATIONAL, 1996, 49 (05) :1304-1313